Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
Alpha Tau Medical Ltd. Class A Ordinary Shares
DRTS | US
8.03
USD0.06
0.75%
DRTS | US
About Alpha Tau Medical Ltd. Class A Ordinary Shares
Sector
Healthcare
Industry
Biotechnology
Earnings date
30/06/2024
As of date
17/04/2026
Close
8.03
Open
8.13
High
8.17
Low
7.85
Alpha Tau Medical Ltd. a clinical-stage oncology therapeutics company engages in research development and commercialization of diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of solid cancer In Israel and the United States. Its Alpha-DaRT technology used in clinical trials for skin oral pancreatic prostate and breast cancers; and preclinical studies for brain hepatic cell carcinoma glioblastoma multiforme lung cancer and others. The company was incorporated in 2015 and is headquartered in Jerusalem Israel.
View LessDRTS | US
Risk
46.1
Sharpe
3.21
Luna's Score
66/100
Recommendation
Buy
Luna says (DRTS | US)
What's Working
Positive Momentum
Low Market Beta (-0.4 to 0.8)
Low Debt to Equity (< 0.25)
Low Debt to Asset (< 0.2)
Value Stock (Price to Book < 3)
Strong Sharpe Ratio (> 1.2)
What's not Working
High 6-Month Volatility (>65%)
Smallcap (300M - 2B USD)
Volatility Signals
Bearish: Increased Volatility (6-month > 1-month volatility)
Risk Meter
10 days
32.0%1 month
46.1%3 months
70.6%6 months
76.7%Returns
Fundamental Ratios
PE
-
Fwd. PE
-
Price to book
2.13
Debt to equity
0.17
Debt to assets
0.13
Ent. to EBITDA
-4.77
Ent. to rev.
-
PEG
-
Other Fundamentals
EBITDA
-35.22M
MarketCap
561.49M
MarketCap(USD)
561.49M
Div. yield
-
Op. margin
-
Erngs. growth
-
Rev. growth
-
Ret. on equity
-33.17
Short ratio
1.60
Short perc.
0.08
Market Sentiment (SMA and Price signals)
Short-term: Bullish (SMA10D > SMA1M)
Intermediate-term: Bullish (SMA1M > SMA3M)
Long-term: Bullish (SMA6M > SMA12M)
SMAs: Stock Price Trends
Range10D
1.54
Range1M
1.89
Range3M
2.50
Volumes: Market Activity
Rel. volume
0.99
Price X volume
2.01M
